National Pension Service’s Royalty Pharma RPRX Stock Holding History

National Pension Service’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$39.7M	Sell	707,178 -35,262	-5%	-$1.84M	0.03%	390
2026 Q1	$35.6M	Buy	+742,440	New	+$32.5M	0.03%	385
2024 Q3	–	Sell	-368,388	Closed	-$9.71M	–	544
2024 Q2	$9.71M	Hold	368,388	–	–	0.01%	486
2024 Q1	$11.2M	Buy	+368,388	New	+$10.9M	0.01%	479

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

National Pension Service's RPRX Position: Q2 2026 in Review

National Pension Service reduced its Royalty Pharma (RPRX) stake by 4.7% in Q2 2026, selling an estimated $1.84M and leaving 707,178 shares worth $39.7M. The position accounts for 0.03% of the portfolio, ranked #390.

National Pension Service first reported a position in RPRX in Q1 2024 and has held it in 4 quarters since. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

National Pension Service held 707,178 shares of Royalty Pharma worth $39.7M as of Q2 2026.
National Pension Service sold 35,262 Royalty Pharma shares in Q2 2026, an estimated $1.84M.
Royalty Pharma made up 0.03% of National Pension Service's portfolio in Q2 2026, its #390 holding.
National Pension Service first reported a position in Royalty Pharma in Q1 2024 and has held it in 4 quarters since.
647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on National Pension Service's 13F filing for Q2 2026, filed 13 Aug 2026.